Based on these results, we have shown preliminary evidence that demethylation of the FAS promoter by 5-aza treatment in LM7 osteosarcoma cells may lead to an improvement in prognosis due to decreased presence of lung metastasis. This evidence concerns the gene FAS and osteosarcoma.